Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2026 09:36 ET | Source: TekniPlex

At MD&M West 2026, TekniPlex Healthcare to Showcase Integrated MedTech CDMO and Sustainable Materials Science Solutions

Wayne, PA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will showcase its interventional and...
January 21, 2026 09:30 ET | Source: John Snow Labs

Redefining Real-World Evidence: John Snow Labs Introduces First FDA-Ready Patient Journey Platform

Designed for secondary use of multimodal, longitudinal patient data, PJI embeds regulatory-grade governance and transparency into every patient journey.
January 21, 2026 09:06 ET | Source: HelloNation Staff Writer

Dental Expert Dr. Marvin Chan Explains Missing Tooth Replacement for HelloNation

Dental expert Dr. Marvin Chan, DMD, AFAAID, FICOI of Advanced Restorative Solutions explains what dental implants are and how they replace a missing tooth.
January 21, 2026 08:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Carboxymethyl Cellulose Market worth $5.04 billion by 2030 at 8.9%, says MarketsandMarkets™

Delray Beach, FL, Jan. 21, 2026 (GLOBE NEWSWIRE) -- In terms of value, the Carboxymethyl Cellulose Market is projected to grow from USD 3.28 billion in 2025 and to reach USD 5.04 billion by 2030, at...
January 21, 2026 08:30 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit

Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced...
January 21, 2026 08:23 ET | Source: BCC Research LLC

AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast

Market growth is fueled by rising R&D investments, increasing trial complexity, and demand for faster, more cost-effective drug development.
January 21, 2026 08:03 ET | Source: AVACTA GROUP PLC

Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)

The Phase 1 clinical study of FAP-Exd (AVA6103) is anticipated to begin later in Q1 2026 LONDON and PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”,...
January 21, 2026 08:00 ET | Source: Centre for Neuro Skills

American Heart Association and Centre for Neuro Skills Deepen Relationship to Advance Stroke and Brain Injury Care

The Centre for Neuro Skills and the American Heart Association have extended their strategic relationship through 2027.
January 21, 2026 08:00 ET | Source: ARS Pharmaceuticals, Inc.

California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use

California joins 23 other states eligible to receive free neffy® (epinephrine nasal spray) at schools SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a...
January 21, 2026 08:00 ET | Source: Arcutis Biotherapeutics, Inc.

Nationwide Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term Treatment Strategies Facing the 46 Million Americans with Chronic Inflammatory Skin Conditions

Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term Treatment Plans For Those With Chronic Inflammatory Skin Conditions